Visalytics
Visalytics
approved EB-2 (NIW)

Ph.D. Student

Biomedical Engineering · Taiwan · 2022-05-21

Processing Time
464 days
Decision Date
2022-05-21
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor bolsters international efforts to enhance cancer treatments and addresses the high prevalence of cancer which burdens U.S. medical and economic resources.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of research experience and a publication record with 102 citations, confirming his status as a leader in biomedical engineering.

3 Balance of Factors Met

The petitioner's work in identifying therapeutic targets and slowing metastasis provides invaluable benefits that outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 9 peer-reviewed journal articles (5 first-authored) and 102 citations, demonstrating wide recognition in the field. The case was supported by 4 recommendation letters and 8 years of direct research experience, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Postdoctoral Researcher

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
69 days 2026-01-26
The petitioner proposes to continue research on elucidating molecular mechanisms and identifying novel therapeutics for rare and advanced metastatic cancers. The work involves using cell-based assays, advanced biotechnological approaches, and computer-aided drug design to advance personalized medicine and improve patient survival outcomes.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-05-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 464 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist